These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 33947317)
1. The non-specific antiviral activity of polysulfates to fight SARS-CoV-2, its mutants and viruses with cationic spikes. Vert M J Biomater Sci Polym Ed; 2021 Aug; 32(11):1466-1471. PubMed ID: 33947317 [TBL] [Abstract][Full Text] [Related]
2. Polyphosphate in Antiviral Protection: A Polyanionic Inorganic Polymer in the Fight Against Coronavirus SARS-CoV-2 Infection. Müller WEG; Wang X; Neufurth M; Schröder HC Prog Mol Subcell Biol; 2022; 61():145-189. PubMed ID: 35697940 [TBL] [Abstract][Full Text] [Related]
3. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Witvrouw M; De Clercq E Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294 [TBL] [Abstract][Full Text] [Related]
4. Long-chain polyphosphates impair SARS-CoV-2 infection and replication. Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209 [TBL] [Abstract][Full Text] [Related]
5. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta. Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999 [TBL] [Abstract][Full Text] [Related]
6. Polycations and polyanions in SARS-CoV-2 infection. Ginsburg I; Fibach E Med Hypotheses; 2021 Jan; 146():110470. PubMed ID: 33412501 [TBL] [Abstract][Full Text] [Related]
7. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy. Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D Cells; 2021 Dec; 11(1):. PubMed ID: 35011614 [TBL] [Abstract][Full Text] [Related]
8. Antiviral Properties of Alginate-Based Biomaterials: Promising Antiviral Agents against SARS-CoV-2. Serrano-Aroca Á; Ferrandis-Montesinos M; Wang R ACS Appl Bio Mater; 2021 Aug; 4(8):5897-5907. PubMed ID: 35006918 [TBL] [Abstract][Full Text] [Related]
9. The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction. Joseph J; Karthika T; Das VRA; Raj VS Curr Pharm Biotechnol; 2022; 23(8):1118-1129. PubMed ID: 34375189 [TBL] [Abstract][Full Text] [Related]
10. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo. Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611 [TBL] [Abstract][Full Text] [Related]
11. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies. Seyedpour S; Khodaei B; Loghman AH; Seyedpour N; Kisomi MF; Balibegloo M; Nezamabadi SS; Gholami B; Saghazadeh A; Rezaei N J Cell Physiol; 2021 Apr; 236(4):2364-2392. PubMed ID: 32901936 [TBL] [Abstract][Full Text] [Related]
18. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro. Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218 [TBL] [Abstract][Full Text] [Related]
19. Antiviral Effect of Budesonide against SARS-CoV-2. Heinen N; Meister TL; Klöhn M; Steinmann E; Todt D; Pfaender S Viruses; 2021 Jul; 13(7):. PubMed ID: 34372616 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines? Mohammed MEA Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]